Searched for
PHARMACEUTICALS COMPANY
Cancer drug prices to fall by up to 96% from November 9; consumers set to save Rs 3,502 crore annuallyStarting November 9, consumers in India will benefit from significantly reduced prices on 137 anti-cancer drugs. The government has capped ...- Pharma industry steps up API investments to cut import dependence, move up value chainIndia's pharmaceutical sector is shifting towards high-value medicines and reducing reliance on imports through local manufacturing. Invest...
- Divi's Labs Q2 Results: PAT surges 64% YoY to Rs 1,127 crore; revenue jumps 35%Divi's Laboratories has achieved a remarkable profit surge of 63.6% year-on-year for the September quarter of FY27, driven by a 35.4% incre...
- Bayer signs MoU with Karnataka government for ₹200 crore manufactuing facility near BengaluruBayer Science and Innovation signed a Memorandum of Understanding with the Karnataka government to establish a manufacturing facility. The ...
- These large-, mid- and small-cap stocks have upside potential of up to 31% in 1 year, according to analystsIn the last two years, the world has learnt that you can never quite predict what US President Trump will do next. Tomorrow, to pull attent...
- Sai Life Sciences shares rally 9% after Q2 results; net profit rises 17%, revenue up 23%Sai Life Sciences shares jumped nearly 9% to a fresh 52-week high after strong second-quarter results. Revenue rose 23%, while net profit i...
- Glenmark Pharma Q2 Results: Net profit plunges 56% to Rs 264 crore, revenue down at Rs 4,247 crGlenmark Pharmaceuticals experienced a 56.78 percent drop in consolidated profit after tax during the September quarter. Total revenue from...
- Pills are paying off! Pharma stocks lead 2026 rally with up to 112% returnIn 2026, India's pharmaceutical stocks are making headlines with impressive year-to-date gains. This surge is driven by strong domestic dem...
- NPPA updates list of reduced MRP of 1,085 anti-cancer drugsThe National Pharmaceutical Pricing Authority updated the maximum retail price for 1,085 anti-cancer medicines. This revision follows a pre...
- HRV Pharma buys Germany's PhateboThe acquisition marks virtual pharmaceutical company HRV's entry beyond active pharmaceutical ingredients (APIs) into finished formulations...
- Emcure Pharma Q2 Results: Profit jumps 29% to Rs 325 croreEmcure Pharmaceuticals Ltd has posted a remarkable consolidated net profit of Rs 325.06 crore for the September quarter, reflecting substan...
- Alkem Laboratories appoints Amrut Naik as CEOAlkem Laboratories announced the appointment of Amrut Naik as its new Chief Executive Officer. His appointment is effective from November 1...
- Emcure Pharma shares jump 7% after Q2 profit rises 29% YoY to Rs 325 croreEmcure Pharmaceuticals shares rose up to 7.3% after the company reported a 29.3% year-on-year increase in Q2 FY27 profit to Rs 325.1 crore....
- Bayer raises 2026 profit outlook on strong pharmaceuticals performanceBayer raised its 2026 profit outlook after its pharmaceuticals division delivered stronger-than-expected third-quarter sales. The German gr...
- Stocks in news: ITC, Marico, SBI, Yatra Online, NSE, Container Corp and Sun PharmaIndian equity benchmarks experienced gains, with Nifty nearing the 23,500 resistance level and strong corporate earnings reported. ITC face...
- Mold-Tek Packaging shares surge 17% as Q2 FY 27 profit jumps 35% YoY to Rs 21 croreMold-Tek Packaging shares surged nearly 17% after the company reported a 35.5% YoY rise in Q2 FY27 net profit and 30.5% revenue growth. Str...
- Short-term headwinds, yes; owning the ecosystem is better: 20 healthcare stocks with downside risk of 23% to upside potential of 41%The healthcare sector is under scrutiny. The issue is pricing: What medicines cost and on what hospitals and the rest of the health ecosyst...
- Pharma company Gufic buys luxury duplex in Mumbai’s Juhu for over Rs 236 crGufic has made a significant real estate purchase with the acquisition of a luxury apartment in Mumbai. The duplex is located in the upscal...
- Sun Pharma Q2 Results: Profit falls 36% YoY to Rs 1,989 crore on exceptional chargesSun Pharma Q2 Results: Revenue from operations rose 12% YoY to Rs 16,199 crore from Rs 14,478 crore in Q2 of last financial year, supported...
- Laurus Labs shares climb 4% after Q2 profit zooms 126% YoYLaurus Labs shares rose 3.79% to Rs 2,329 after the pharmaceutical company reported strong Q2FY27 results. Revenue increased 33% year-on-ye...
Load More
